Events

Poster

Development and Validation of a Novel T Cell Modulating, Microbiome-Based Peptide for Combination with Immunotherapy

  • Presented by:
    Archana Nagaraja, Ph.D.
  • Event:
    AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  • Venue:
    Online
  • Dates:
    October 7-10, 2021
  • Click here for webcast
Poster

A Novel Microbiome‑Derived Peptide, SG‑3‑00802 Reverses Resistance to Anti‑Programmed Death Protein‑1 (PD‑1) Therapy

Talk

Helios2(Neo4j) for Discovering Drugs and Biomarkers

  • Presented by:
    Satish Viswanatham
  • Event:
    Neo4j Accelerating Innovation with Graphs
  • Venue:
    Virtual
  • Click here for webcast
Poster

Metabolites Predicted from Multiple Microbiome Sequencing Datasets Modulate Autism Spectrum Phenotype in Mice

Poster

Novel Multi-Technology Microbiome Meta-Analysis in IBD Identifies Bacterial Peptides that Modulate IBD-Relevant T Cell Activity

Scientific Conference

4th Annual Next Gen Immuno-Oncology Virtual Congress

Scientific Conference

Microbiome Data Congress 2021

Investor Conference

Jefferies Microbiome-Based Therapeutics Summit

  • Presented by:
    Karim Dabbagh, Ph.D.
  • Venue:
    Online
  • Dates:
    April 22, 2021 at 8:00 a.m. ET
  • Click here for webcast
Talk

Discovery of Pharmacological Agents Emitted by Intestinal Bacteria

Talk

Microbiome-based biomarker predicts response to immune checkpoint inhibitor therapy in a melanoma meta-cohort independently of clinical features